Human Pathology: Case Reports (Dec 2015)

Her-2 neu negative lipid rich breast carcinoma in an immunocompromised patient

  • Deepika Sirohi, M.D.,
  • Kent Swimley,
  • Amanda L. Profit, M.D.,
  • Nicole D. Riddle, M.D.

DOI
https://doi.org/10.1016/j.ehpc.2015.04.002
Journal volume & issue
Vol. 2, no. 4
pp. 99 – 102

Abstract

Read online

Lipid-rich breast carcinoma (LRBC) is rare cancer considered to be a variant of invasive ductal breast carcinoma. It is characterized by an aggressive behavior and poor prognosis and requires prompt recognition and close follow-up. The tumor derives its name from the intracytoplasmic neutral lipid that gives it a vacuolated appearance and is included in the current WHO classification. We report here a case of Her-2 neu negative lipid-rich carcinoma of the breast occurring in a HIV positive woman.

Keywords